# Minimization of IntraLipid Versus Omegaven

> **NCT01247012** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Children's & Women's Health Centre of British Columbia** · enrollment: 40 (estimated)

## Conditions studied

- Cholestasis
- Parenteral Nutrition Associated Liver Disease (PNALD)

## Interventions

- **DIETARY_SUPPLEMENT:** Omegaven
- **DIETARY_SUPPLEMENT:** Lipid minimization

## Key facts

- **NCT ID:** NCT01247012
- **Lead sponsor:** Children's & Women's Health Centre of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-12
- **Primary completion:** 2012-12
- **Final completion:** 2012-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2011-09-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01247012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01247012, "Minimization of IntraLipid Versus Omegaven". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01247012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*